Dick C. Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dick C. Chan has a total of 311 co-authors. Here are the top co-authors by number of shared publications:
- Gerald Francis Watts
Medical School, University of Western Australia, Perth, WA 6009, Australia
151 shared publications - P. Hugh R. Barrett
Faculty of Medicine and Health, University of New England, Armidale, Australia
88 shared publications - Esther M. M. Ooi
School of Biomedical Sciences, University of Western Australia, Perth, Australia
36 shared publications - Jing Pang
Medical School, University of Western Australia, Western Australia, Australia
32 shared publications - Theodore W. K. Ng
Metabolic Research Centre (T.W.K.N., E.M.M.O., G.F.W., D.C.C., P.H.R.B.), School of Medicine and Pharmacology, and Faculty of Engineering (P.H.R.B.), Computing and Mathematics, Perth, Western Australia, Australia; and Metabolomics Laboratory (T.W.K.N., J.M.W., P.J.M.), Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia
15 shared publications Jing Pang
Medical School, University of Western Australia, Perth, Australia
10 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 11 (10)
Lipoprotein(a) Particle Core Remodeling and Apolipoprotein C-III Inhibition
- 17 September 2026
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 11 (10)
Open AccessLipoprotein(a) Particle Core Remodeling and Apolipoprotein C-III Inhibition
- Open Access
- 24 August 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (10) , 2172-2179
Temporal aspects and implications of the measurement of lipoprotein(a) in patients with acute myocardial infarction
- 24 August 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (10) , 2172-2179
Open AccessTemporal aspects and implications of the measurement of lipoprotein(a) in patients with acute myocardial infarction
- Open Access
- 13 August 2026
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (10) , 2195-2204
High resolution lipoprotein subfraction profiling identifies obesity associated distributional changes in LDL and HDL subfractions and particle ratios
Background: Obesity is associated with adverse alterations in lipoprotein profiles and increased cardiometabolic risk, yet standard clinical lipid measures provide limited resolution of the underlying lipoprotein structure. Here, we perform a population-level characterisation of the impact of obesity on the high-resolution blood lipoprotein subfraction profile. Methods: Lipoprotein profiles were investigated in an Australian cohort ( n = 1806) stratified by Body Mass Index (BMI) (healthy weight, overweight, obese). The composition and particle number of lipoproteins and their subfractions were quantified ( n = 112 parameters) using 1 H NMR spectroscopy. Associations between BMI, lipoprotein subfractions, and particle number ratios were evaluated. Key BMI-associated ratios were validated in a second Australian cohort ( n = 1313) Results: Participants with obesity had significantly higher particle concentrations of VLDL and IDL and lower HDLs, while total LDL concentration was similar between the BMI categories. Notably, obesity was associated with a marked redistribution of LDL subfractions, with a shift from larger, buoyant LDL1–3 particles to smaller, dense LDL4–6 particles, accompanied by a similar shift in HDL subfractions, with proportionally lower concentrations of HDL1–3 particles in the high BMI group. An inverse association between BMI was found for two LDL particle number ratios (LDL1–3:LDL4–6 and LDL2:LDL5) and one HDL ratio (HDL1:HDL4), which demonstrated good discriminatory power for obesity status (AUROCs 0.70–0.74). Conclusions: The pattern of lipoprotein subfraction redistribution in participants with obesity was consistent across cohorts. These subfractional changes offer enhanced resolution compared with conventional lipid and lipoprotein measures and may contribute to improved cardiovascular risk stratification in individuals with obesity.
- 13 August 2026
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (10) , 2195-2204
Open AccessHigh resolution lipoprotein subfraction profiling identifies obesity associated distributional changes in LDL and HDL subfractions and particle ratios
Background: Obesity is associated with adverse alterations in lipoprotein profiles and increased cardiometabolic risk, yet standard clinical lipid measures provide limited resolution of the underlying lipoprotein structure. Here, we perform a population-level characterisation of the impact of obesity on the high-resolution blood lipoprotein subfraction profile. Methods: Lipoprotein profiles were investigated in an Australian cohort ( n = 1806) stratified by Body Mass Index (BMI) (healthy weight, overweight, obese). The composition and particle number of lipoproteins and their subfractions were quantified ( n = 112 parameters) using 1 H NMR spectroscopy. Associations between BMI, lipoprotein subfractions, and particle number ratios were evaluated. Key BMI-associated ratios were validated in a second Australian cohort ( n = 1313) Results: Participants with obesity had significantly higher particle concentrations of VLDL and IDL and lower HDLs, while total LDL concentration was similar between the BMI categories. Notably, obesity was associated with a marked redistribution of LDL subfractions, with a shift from larger, buoyant LDL1–3 particles to smaller, dense LDL4–6 particles, accompanied by a similar shift in HDL subfractions, with proportionally lower concentrations of HDL1–3 particles in the high BMI group. An inverse association between BMI was found for two LDL particle number ratios (LDL1–3:LDL4–6 and LDL2:LDL5) and one HDL ratio (HDL1:HDL4), which demonstrated good discriminatory power for obesity status (AUROCs 0.70–0.74). Conclusions: The pattern of lipoprotein subfraction redistribution in participants with obesity was consistent across cohorts. These subfractional changes offer enhanced resolution compared with conventional lipid and lipoprotein measures and may contribute to improved cardiovascular risk stratification in individuals with obesity.
- Open Access
- 21 April 2026
- Published by Elsevier in Atherosclerosis
- Vol. 415, 120650
Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis
- 21 April 2026
- Published by Elsevier in Atherosclerosis
- Vol. 415, 120650
Open AccessRisk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis
- Open Access
- 8 November 2025
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (3) , 104457
Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia
- 8 November 2025
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (3) , 104457
Open AccessAssociation of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia
- 10 September 2025
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 121 (12) , 1796-1797
A new PCSK-9 monoclonal antibody for lowering LDL-cholesterol and lipoprotein(a) in Chinese patients with familial hypercholesterolaemia
- 10 September 2025
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 121 (12) , 1796-1797
A new PCSK-9 monoclonal antibody for lowering LDL-cholesterol and lipoprotein(a) in Chinese patients with familial hypercholesterolaemia
- 10 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (7) , e1916-e1917
Female-Specific Risk of Pancreatitis in Severe Hypertriglyceridemia: Implications for Family Planning and New Guidelines
- 10 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (7) , e1916-e1917
Female-Specific Risk of Pancreatitis in Severe Hypertriglyceridemia: Implications for Family Planning and New Guidelines
- Open Access
- 22 August 2025
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 41 (11) , 2244-2251
Canadian and French Risk Scores Are Valid in Identifying Cardiovascular Disease in Australian Patients With Familial Hypercholesterolemia
- 22 August 2025
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 41 (11) , 2244-2251
Open AccessCanadian and French Risk Scores Are Valid in Identifying Cardiovascular Disease in Australian Patients With Familial Hypercholesterolemia
- 4 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (19) , 1849-1851
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
- 4 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (19) , 1849-1851
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies